Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Accounts Payables (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Accounts Payables data on record, last reported at $22.7 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 5.6% year-over-year to $22.7 million; the TTM value through Oct 2025 reached $22.7 million, up 5.6%, while the annual FY2025 figure was $27.0 million, 16.21% up from the prior year.
  • Accounts Payables reached $22.7 million in Q4 2025 per KEQU's latest filing, down from $26.3 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $27.4 million in Q1 2022 and bottomed at $16.0 million in Q1 2021.
  • Average Accounts Payables over 5 years is $22.4 million, with a median of $22.9 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: surged 71.39% in 2022, then dropped 23.4% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $20.2 million in 2021, then rose by 13.95% to $23.0 million in 2022, then fell by 16.82% to $19.2 million in 2023, then rose by 11.92% to $21.5 million in 2024, then increased by 5.6% to $22.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $22.7 million in Q4 2025, $26.3 million in Q3 2025, and $27.0 million in Q2 2025.